AstraZeneca PLC Pledges $150M Russia Plant Investment

February 18, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MOSCOW, Feb 17 (Reuters) - AstraZeneca (AZN.L) will invest more than $150 million in building a Russian plant, joining rivals looking to sidestep tougher rules on imported medicines as Russia drives to support domestic industry.

Twitter
LinkedIn
Facebook
Email
Print

Real estate Europe

AstraZeneca Pharmaceuticals LP